Biotech Investors & VC Firms in Asia-Pacific
571 firms in this list, with a median first check of $650K. 110 of them lead rounds. Generated from verified public data and updated continuously.
INCJ, Ltd.
TokyoSeed–Late Stage
1 person
Brandon Capital Partners
Seed–Growth
YF Capital
Hong KongSeed–Late Stage
East Gate Partners
SeoulSeed–Series A
2 people
Global Venture Capital, Inc.
TokyoSeed–Series A
2 people
Hanne Capital
ShanghaiSeed–Late Stage
2 people
Malaysia Debt Ventures Bhd.
Kuala LumpurSeed–Late Stage
2 people
Shenzhen Leaguer Tsing-Yuan Venture Capital Management Co., Ltd.
ShenzhenSeed–Series B
2 people
Tohoku Innovation Capital Corporation
MiyagiSeed–Series A
2 people
Shanghai STVC Group
ShanghaiSeed–Late Stage
1 person
Bio Sight Capital, Inc.
OsakaSeed–Series A
1 person
Dooghoon Investment Co.
SeoulSeed–Series A
1 person
Ilshin Investment Co. Ltd.
SeoulSeed–Late Stage
1 person
3H Health Investment
ShanghaiSeries A–Late Stage
E-Crowd
Seed–Growth
Ikemori Venture Support
TokyoSeed
Capital Medica Ventures
TokyoPre-Seed–Growth
Lake Bleu Capital
Hong KongSeed–Growth
PTV Healthcare Capital
SingaporeSeries B–Late Stage
Santen Pharmaceutical
OsakaSeries A–Series C
SDIC Venture Capital
BeijingSeed–Late Stage
Venture Labo Investment
TokyoSeed–Late Stage
EISAI CO.,LTD
TokyoSeed–Growth
Hong Kong X Technology Fund
Hong KongSeed–Growth
Related lists
Investors & VC Firms in North America (13808)Investors & VC Firms in United States (12951)Investors & VC Firms in Europe (5511)Crypto & Web3 Investors & VC Firms (4813)Investors & VC Firms in Global (4134)SaaS Investors & VC Firms (3860)AI & Machine Learning Investors & VC Firms (3764)Fintech Investors & VC Firms (3709)Investors & VC Firms in Asia-Pacific (3560)Healthtech Investors & VC Firms (3408)
Data sourced from public filings and firms' own websites — see our methodology.
